Skip to main content
TDACU logo

TDACU · Translational Development Acquisition Corp.

Track TDACU — free
$11.48 At close · Oct 13
Market Cap
$208.73M
Shares
19.31M
Volume · Oct 13 101 Avg daily vol (7 sessions) 355

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$11.48 Open$11.48 Day$11.48–11.48 Available close range$10.71–17.29 Avg vol 30d2K DataDec 2024–Oct 2026 Filing10-Q · Aug 14

The closing range uses available history since May 26, 2026; less than a full year is stored.

Up next

filed Aug 14, 2026

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Distributing
-9% holders QoQ · +7 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
No short-interest data
Volume signal Normal
Volume near normal
Institution breadth Steady
49 holders — mid 1-yr range
Price context
position in its available closing range
Range low $11 Now $11 · 12% Range high $17
vs 50-day avg +2%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.

Versus peers

Shell Companies — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
TDACU
Translational Development Acquisition Corp.
this stock
$208.73M — — — —
VYLR
Vylor Inc.
$47.46B — — — —
CLUS
Cluster Group Holdings Ltd Co
$8.00B — — — —
DMII
Drugs Made In America Acquisition II Corp.
$649.10M +2.9% — — 0.2%
EVAC
EQV Ventures Acquisition Corp. II
$603.77M +3.0% — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
49
% held
113.5%
Net QoQ
-2.9M sh
Top holder
Linden Advisors LP
Held Float
View
Short & Settlement
Fails to Deliver
FTD shares
274
Value
$3.0K
As of
Sep 14, 2026
View
Financials
Financials
Net income (FY)
$6.4M
View
Filings
SEC Filings
Latest
10-Q
Filed
Aug 14, 2026
This year
12
View

Performance

5D 20D 120D MTD YTD
TDACU -0.6% +7.2% +14.7% -8.7% +10.0%
SPY -0.1% +2.7% +9.4% +2.0% +14.1%
vs SPY -0.5% +4.5% +5.3% -10.7% -4.1%
Key facts CIK 1926599 CUSIP G9008W105 Visit website Investor relations